July 19, 2011
Aventis Pharmaceuticals Inc. on Monday settled with generics maker Sun Pharmaceutical Industries Ltd. in two New Jersey suits over a proposed generic version of the allergy drug Allegra, which Aventis claimed would infringe eight of its patents for the medication.